Prague, Czechia

Petr Mikes

This inventor holds 1 USPTO granted patent. Top assignee: Sanofi. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Petr Mikes. Retrieved from https://idiyas.com/inventor/petr-mikes-1eqahbuk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Petr Mikes

Introduction

Petr Mikes is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent. His work focuses on the development of pharmaceutical compositions that combine effective active ingredients for improved health outcomes.

Latest Patents

Petr Mikes holds a patent for a pharmaceutical composition comprising rosuvastatin and ezetimibe, along with a preparation method for this composition. The invention relates to a pharmaceutical composition that includes rosuvastatin, known for its cholesterol-lowering properties, and ezetimibe, which also aids in reducing cholesterol absorption. The specific weight ratio of the layers in this composition ranges from 1:2 to 2:1, enhancing its efficacy.

Career Highlights

Petr Mikes is associated with Sanofi, a leading global healthcare company. His role at Sanofi allows him to contribute to the development of innovative pharmaceutical solutions that address critical health issues. His expertise in pharmaceutical compositions has positioned him as a valuable asset in the industry.

Collaborations

Petr collaborates with talented colleagues such as Jaroslava Svobodova and Alena Prokopova. Their combined efforts in research and development foster an environment of innovation and creativity within their projects.

Conclusion

Petr Mikes exemplifies the spirit of innovation in the pharmaceutical industry through his patent and contributions at Sanofi. His work not only advances medical science but also improves patient care and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…